Company Search:
Advanced Search
Sponsored Links
Yifan Pharmaceutical Co Ltd Company Snapshot
Yifan Pharmaceutical Co Ltd operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Yifan Pharmaceutical Co Ltd with three other companies in this sector in China: China Biologic Products Holdings Inc (2016 sales of 2.27 billion Chinese Renmimbi [US$358.53 million] of which 100% was Human Blood Product), Shanghai Raas Blood Products Company Limited (2.33 billion Chinese Renmimbi [US$367.43 million] of which 97% was Blood products production and sales), and China Animal Husbandry Ind. (3.97 billion Chinese Renmimbi [US$627.67 million] of which 48% was Animal Feedstuff).

Sales Analysis. Yifan Pharmaceutical Co Ltd reported sales of 3.50 billion Chinese Renmimbi (US$553.45 million) for the year ending December of 2016. This represents an increase of 43.9% versus 2015, when the company's sales were 2.43 billion Chinese Renmimbi. Sales at Yifan Pharmaceutical Co Ltd have increased during each of the previous five years (and since 2011, sales have increased a total of 607%). Sales of Medicine Material and Macromolecular saw an increase that was more than double the company's growth rate: sales were up 106.5% in 2016, from 777.74 million Chinese Renmimbi to 1.61 billion Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Yifan Pharmaceutical Co Ltd
  Stock Performance Chart for Yifan Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 21.41
(Figures in Chinese Renmimbi)
1 Week -3.7%   13 Weeks 11.5%  
4 Weeks -3.2%   52 Weeks 28.7%  
Yifan Pharmaceutical Co Ltd Key Data:
  Ticker: 002019 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 3,503,926,450
(Year Ending Jan 2017).
Employees: 3,607
  Currency: Chinese Renmimbi Market Cap: 25,841,325,694
  Fiscal Yr Ends: December Shares Outstanding: 1,206,974,577
  Share Type: A Shares Closely Held Shares: 585,070,854
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.